Skip to content

Optimizing Analgesia for Endometrial Biopsy

Optimizing Analgesia for Endometrial Biopsy: A Prospective, Randomized Comparative Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06540599
Enrollment
197
Registered
2024-08-06
Start date
2022-09-01
Completion date
2022-11-01
Last updated
2024-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia

Keywords

endometrial biopsy, intrauterine lidocaine, pain management

Brief summary

Comparison of the effectiveness of intrauterine lidocaine-paracervical block-dexketoprofen tromematol- lidocaine spray in endometrial biopsy analgesia

Interventions

DRUGAnalgesic

comparing the effectiveness of analgesics in endometrial biopsy

Sponsors

Gaziosmanpasa Research and Education Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* women aged 18-75 needs endometrial biopsy

Exclusion criteria

* women with allergies to prilocaine, lidocaine or dexketoprofen trometamol * women with a history of severe uncontrolled cardiovascular disease, diabetes mellitus, pregnancy, vaginal, cervical, or pelvic infection, cervical cancer, or severe cervical stenosis

Design outcomes

Primary

MeasureTime frameDescription
comparing analgesics in endometrial biopsy using The Visual Analogue Scale (VAS).1 hourpost operative VAS scores will be compared for each drug.The VAS measures pain intensity. The VAS consists of a 10 cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). In this context, higher scores represent worse results.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026